Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Levy, G. N.
Right arrow Articles by Weber, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, G. N.
Right arrow Articles by Weber, W. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

2-Aminofluorene-DNA adduct formation in acetylator congenic mouse lines

Gerald N. Levy and Wendell W. Weber

Department of Pharmacology, University of Michigan Ann Arbor, M1 48103, USA

The effect of the acetylator polymorphism on hepatic 2-aminofluorene-DNA adduct formation in mice was studied using two recent developments from our laboratory. Acetylator congenic mouse lines differing from their parental inbred lines in N-acetyltransferase activity were used to separate the effect of the N-acetyltransferase polymorphism from effects of differences in other genetically polymorphic enzymes. DNA adduct formation was used as an indicator of arylamine induced DNA damage. Adduct formation was measured by HPLC analysis of 3 nucleotides from hepatic DNA of treated animals. At a high dose (60 mg/kg) of 2-aminofluorene for a 3 h exposure, rapid acetylator mice (C57BL/6J) accumulated twice the adducts of slow acetylators (A/J). In acetylator congenic mice this difference increased so that rapid acetylators with the slow background (A.B6-Nat1) had 5- to 7-times the DNA damage of the slow acetylator congenic with the rapid background (B6.A-Nat5). It was also found that within each mouse line examined, females had higher levels of adduct formation than males. Acetylator congenic mouse lines were useful in distinguishing the effect of acetylator genes from the total genetic background. Similarly, congenics were useful in demonstrating the contribution that enzymes other than N-acetyltransferase make to differences in adduct formation in inbred mouse lines.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
K. S. Sugamori, D. Brenneman, S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, and D. M. Grant
Effect of Arylamine Acetyltransferase Nat3 Gene Knockout on N-Acetylation in the Mouse
Drug Metab. Dispos., July 1, 2007; 35(7): 1064 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. S. Sugamori, D. Brenneman, and D. M. Grant
In Vivo and in Vitro Metabolism of Arylamine Procarcinogens in Acetyltransferase-Deficient Mice
Drug Metab. Dispos., October 1, 2006; 34(10): 1697 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. S. Sugamori, S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, and D. M. Grant
Generation and Functional Characterization of Arylamine N-Acetyltransferase Nat1/Nat2Double-Knockout Mice
Mol. Pharmacol., July 1, 2003; 64(1): 170 - 179.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Leff, P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan, and D. W. Hein
Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 182 - 187.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.